479 related articles for article (PubMed ID: 12370796)
1. Magnesium deficiency: effect on bone and mineral metabolism in the mouse.
Rude RK; Gruber HE; Wei LY; Frausto A; Mills BG
Calcif Tissue Int; 2003 Jan; 72(1):32-41. PubMed ID: 12370796
[TBL] [Abstract][Full Text] [Related]
2. Dietary magnesium reduction to 25% of nutrient requirement disrupts bone and mineral metabolism in the rat.
Rude RK; Gruber HE; Norton HJ; Wei LY; Frausto A; Kilburn J
Bone; 2005 Aug; 37(2):211-9. PubMed ID: 15923157
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
Saidenberg-Kermanac'h N; Corrado A; Lemeiter D; deVernejoul MC; Boissier MC; Cohen-Solal ME
Bone; 2004 Nov; 35(5):1200-7. PubMed ID: 15542046
[TBL] [Abstract][Full Text] [Related]
4. Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.
Schett G; Redlich K; Hayer S; Zwerina J; Bolon B; Dunstan C; Görtz B; Schulz A; Bergmeister H; Kollias G; Steiner G; Smolen JS
Arthritis Rheum; 2003 Jul; 48(7):2042-51. PubMed ID: 12847699
[TBL] [Abstract][Full Text] [Related]
5. TNFalpha receptor knockout in mice reduces adverse effects of magnesium deficiency on bone.
Rude RK; Wei L; Norton HJ; Lu SS; Dempster DW; Gruber HE
Growth Factors; 2009 Dec; 27(6):370-6. PubMed ID: 19919525
[TBL] [Abstract][Full Text] [Related]
6. Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption.
Rude RK; Kirchen ME; Gruber HE; Meyer MH; Luck JS; Crawford DL
Magnes Res; 1999 Dec; 12(4):257-67. PubMed ID: 10612083
[TBL] [Abstract][Full Text] [Related]
7. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin ameliorates sciatic nerve crush induced bone loss.
Bateman TA; Dunstan CR; Lacey DL; Ferguson VL; Ayers RA; Simske SJ
J Orthop Res; 2001 Jul; 19(4):518-23. PubMed ID: 11518255
[TBL] [Abstract][Full Text] [Related]
9. Alterations in osteoclast morphology following osteoprotegerin administration in the magnesium-deficient mouse.
Gruber HE; Rude RK
Biotech Histochem; 2003 Oct; 78(5):231-6. PubMed ID: 14989640
[TBL] [Abstract][Full Text] [Related]
10. Dietary calcium and phosphorus ratio regulates bone mineralization and turnover in vitamin D receptor knockout mice by affecting intestinal calcium and phosphorus absorption.
Masuyama R; Nakaya Y; Katsumata S; Kajita Y; Uehara M; Tanaka S; Sakai A; Kato S; Nakamura T; Suzuki K
J Bone Miner Res; 2003 Jul; 18(7):1217-26. PubMed ID: 12854831
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.
Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S
Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235
[TBL] [Abstract][Full Text] [Related]
12. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
13. Differential mRNA expression profiles in proximal tibia of aged rats in response to ovariectomy and low-Ca diet.
Zhang Y; Dong XL; Leung PC; Wong MS
Bone; 2009 Jan; 44(1):46-52. PubMed ID: 18848653
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice.
Nakano Y; Watanabe K; Morimoto I; Okada Y; Ura K; Sato K; Kasono K; Nakamura T; Eto S
J Bone Miner Res; 1994 Oct; 9(10):1533-9. PubMed ID: 7817798
[TBL] [Abstract][Full Text] [Related]
16. Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice.
Zhang J; Dai J; Lin DL; Habib P; Smith P; Murtha J; Fu Z; Yao Z; Qi Y; Keller ET
J Bone Miner Res; 2002 Jul; 17(7):1256-63. PubMed ID: 12096839
[TBL] [Abstract][Full Text] [Related]
17. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
Wang FS; Ko JY; Lin CL; Wu HL; Ke HJ; Tai PJ
Bone; 2007 Feb; 40(2):485-92. PubMed ID: 17055793
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin treatment impairs remodeling and apparent material properties of callus tissue without influencing structural fracture strength.
Ulrich-Vinther M; Andreassen TT
Calcif Tissue Int; 2005 Apr; 76(4):280-6. PubMed ID: 15812581
[TBL] [Abstract][Full Text] [Related]
19. A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3.
Morony S; Capparelli C; Lee R; Shimamoto G; Boone T; Lacey DL; Dunstan CR
J Bone Miner Res; 1999 Sep; 14(9):1478-85. PubMed ID: 10469275
[TBL] [Abstract][Full Text] [Related]
20. Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures.
Kaji H; Kanatani M; Sugimoto T; Chihara K
Horm Metab Res; 2005 Oct; 37(10):589-92. PubMed ID: 16278780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]